Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura. [electronic resource]
Producer: 19990513Description: 1740-9 p. digitalISSN:- 0008-543X
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Asbestos -- adverse effects
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Etoposide -- administration & dosage
- Female
- Filgrastim
- Fluorouracil -- administration & dosage
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Hematologic Diseases -- chemically induced
- Humans
- Immunotherapy
- Leucovorin -- therapeutic use
- Male
- Mesothelioma -- drug therapy
- Middle Aged
- Mitomycin -- administration & dosage
- Pleural Neoplasms -- drug therapy
- Prospective Studies
- Recombinant Proteins
- Remission Induction
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.